NYMC Faculty Publications
Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines
DOI
10.1007/s40265-018-0887-5
Journal Title
Drugs
First Page
567
Last Page
576
Document Type
Article
Publication Date
April 2018
Department
Medicine
Abstract
The 2017 American College of Cardiology/American Heart Association hypertension guidelines diagnose hypertension if systolic blood pressure (SBP) is >/= 130 mmHg or diastolic blood pressure (DBP) is >/= 80 mmHg. Increased BP is SBP 120-129 mmHg with DBP /= 130 mmHg or an average DBP >/= 80 mmHg. Lifestyle measures plus BP-lowering drugs should be used for primary prevention of cardiovascular disease in individuals with an estimated 10-year risk of atherosclerotic cardiovascular disease (ASCVD) >/= 10% and an average SBP >/= 130 mmHg or an average DBP >/= 80 mmHg. Lifestyle measures plus BP-lowering drugs should be used for primary prevention of cardiovascular disease in individuals with an estimated 10-year risk of ASCVD /= 140 mmHg or an average DBP >/= 90 mmHg. White coat hypertension must be excluded before starting antihypertensive drug treatment in individuals with hypertension with a low risk for ASCVD. BP should be lowered to 65 years. The selection of antihypertensive drug treatment is discussed.
Recommended Citation
Aronow, W. S., & Frishman, W. H. (2018). Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines. Drugs, 78 (5), 567-576. https://doi.org/10.1007/s40265-018-0887-5
